18F-Fluciclovine: A New Option for Biochemical Recurrence in Prostate Cancer - Trond V. Bogsrud

(Length of lecture ~ 15 minutes)

Trond V. Bogsrud, MD presented "18F-Fluciclovine: A New Option for Biochemical Recurrence in Prostate Cancer” at the SNMMI 2016, detailing the uptake of fluciclovine (18F) as a PET imaging radiotracer in comparison to other PET tracers in patients with biochemically recurrent prostate cancer.

Additional content on 18F - Fluciclovine

Stepping Into the Light: "Radiologist Dies Upon Immediate Exposure to Sunlight.”

New Hot Topic: Axumin™ (Fluciclovine F 18) Injection for PET Imaging of Recurrent Prostate Cancer - Phillip Koo


EVERYDAY UROLOGY: Axumin™ [Fluciclovine F18]: An Accurate Imaging Approach for Patients with Biochemically Recurrent Prostate Cancer-Full text article

Using Fluciclovine in the Recurrent Prostate Cancer Patient- David Schuster

Biography:
Trond V. Bogsrud, MD, PHD, Oslo University Hospital, Department of Radiology and Nuclear Medicine